1 / 4

W/T mice

W/T mice. Proteinuria (mg/dl). IL-10 -/- mice. Aged MRL/lpr. Weeks post-injection.

burian
Download Presentation

W/T mice

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. W/T mice Proteinuria (mg/dl) IL-10-/- mice Aged MRL/lpr Weeks post-injection Suppl. Fig. 1: Detection of proteinuria. Groups of W/T and IL-10-/- mice (8-wks of age, female) were injected, for three times and at bi-week intervals, with 1x106 syngenic DCs that had been preloaded with necrotic cells prepared either by the freeze-thaw (DC/necF/T) or heat-shock (DC/necH/S) procedures (see Methods), or with DC alone (DC) or PBS alone (PBS). Urine samples were collected bi-weekly and tested for the levels of proteinuria in the different treatment groups of both strains. For comparison, solid bars represent proteinuria levels detected in a group of aged lupus-prone MRL/lpr mice (16-wks old, n = 10). Data shown were the average levels (Mean + SE) calculated from mice of the respective groups, and the number of mice in each group indicated above (n).

  2. W/T IL-10-/- Anti-dsDNA (IgG, AEU/ml) Anti-ssDNA (IgG, AEU/ml) Anti-chromatin (IgG, AEU/ml) Anti-histone (IgG, AEU/ml) Anti-SM//nRNP (IgG, AEU/ml) Weeks post-injection Suppl. Fig. 2:Serum autoantibody levels.Serum samples were taken from the mice described in Methods, at the indicated time points. Levels of 5 classical lupus-associated autoantibodies, i.e. anti-dsDNA, anti-ssDNA, anti-chromatin, anti-histone and anti-SM/nRNP, were quantified by ELISAs. Autoantibody levels against dsDNA and ssDNA were measured in all of the 4 treatment groups. Those against chromatin, histone and SM/RNP were measured selectively in the 2 main treatment groups (DC/necF/T, DC/necF/T) in comparison to those of DC alone control groups. Data shown are mean ± SEM calculated from individual mice of each group (n = 4-5). Arrows indicate the time of 3 injections given.

  3. IgG1 (AEU/ml) Serum anti-dsDNA antibodies of different isotypes IgG2b (AEU/ml) IgG2c/IgG2ab (AEU/ml) Suppl. Fig. 3: Isotypic analysis of serum anti-dsDNA antibodies induced by DC/nec treatments. Serum samples taken 8-weeks after DC/nec treatments were assayed for the subclasses of anti-dsDNA antibodies in the circulation. Data shown are mean±SEM calculated from individual mice of each group (n = 4-5).N.D = not detected. Serum samples from the PBS-treated groups contained no or very low level of anti-DNA antibodies (total IgG), hence were not included in the isotypic analysis.

  4. B A C D Suppl. Fig. 4: Characterization of the renal reactive autoantibodies in blood circulation.Frozen kidney sections prepared from normal C57BL/6 mice were used as the source of target autoantigens in this immunoreactivity assay. Serum samples taken from IL-10-/- mice treated with DC/necF/T (A), or DC/necH/S (B), and WT mice-treated with DC/necH/S (C) (8wks post 1st DC injection) were applied and incubated, followed by the FITC-conjugated goat anti-mouse IgG secondary antibody. Photomicrographs shown are results representative of 3 independent experiments. (D) Negative control: No serum (secondary antibody only).

More Related